T. Bosse
International Journal of Gynecological Cancer · 2015–2020
A researcher in the Science corpus: 7 papers; trusts 0 researchers and is trusted by 0 researchers here, as inferred from the citation graph.
Papers from T. Bosse's perspective
Ordered by how strongly the researchers T. Bosse trusts endorse each paper. Same corpus, a different order for every researcher.
- MSIsensor: microsatellite instability detection using paired tumor-normal sequence data (Bioinform.)
- REporting recommendations for tumour MARKer prognostic studies (REMARK) (British Journal of Cancer)
- Integrated Genomic Characterization of Endometrial Carcinoma (Nature)
- Endometrial cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. (Annals of Oncology)
- Survival effect of para-aortic lymphadenectomy in endometrial cancer (SEPAL study): a retrospective cohort analysis. (The Lancet)
- Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium
- A clinically applicable molecular-based classification for endometrial cancers (British Journal of Cancer)
- Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial
- Prospective assessment of lymphatic dissemination in endometrial cancer: a paradigm shift in surgical staging. (Gynecologic Oncology)
- Evaluation of tumor microsatellite instability using five quasimonomorphic mononucleotide repeats and pentaplex PCR. (Gastroenterology)
Their papers
- Molecular Classification of the PORTEC-3 Trial for High-Risk Endometrial Cancer: Impact on Prognosis and Benefit From Adjuvant Therapy (2020) — 654 citations
- ESGO/ESTRO/ESP guidelines for the management of patients with endometrial carcinoma (2020) — 1,756 citations
- ESMO recommendations on microsatellite instability testing for immunotherapy in cancer, and its relationship with PD-1/PD-L1 expression and tumour mutational burden: a systematic review-based approach. (2019) — 896 citations
- An organoid platform for ovarian cancer captures intra- and interpatient heterogeneity (2019) — 718 citations
- Improved Risk Assessment by Integrating Molecular and Clinicopathological Factors in Early-stage Endometrial Cancer—Combined Analysis of the PORTEC Cohorts (2016) — 726 citations
- ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer (2015) — 904 citations
- ESMO-ESGO-ESTRO consensus conference on endometrial cancer: Diagnosis, treatment and follow-up. (2015) — 642 citations